Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Contraception and Contraceptive Drugs

  Free Subscription

Articles published in Hum Reprod

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    November 2022
  1. KANGASNIEMI MH, Arffman RK, Joenvaara S, Haverinen A, et al
    Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Hum Reprod. 2022 Nov 23:deac250. doi: 10.1093.
    PubMed     Abstract available

    September 2022
  2. LEE SG, Kiattiburut W, Khongkha T, Schinkel SCB, et al
    17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae.
    Hum Reprod. 2022 Sep 2. pii: 6687171. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  3. HUBACHER D, Byamugisha J, Kakaire O, Nalubwama H, et al
    Removal of a well-palpable one-rod subdermal contraceptive implant using a dedicated hand-held device or standard technique: a randomized, open-label, non-inferiority trial.
    Hum Reprod. 2022 Aug 12. pii: 6663786. doi: 10.1093.
    PubMed     Abstract available

    July 2022
  4. ZHOU C, Yang X, Wang Y, Xi J, et al
    Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
    Hum Reprod. 2022;37:1795-1805.
    PubMed     Abstract available

    May 2022
  5. KROG MC, Hugerth LW, Fransson E, Bashir Z, et al
    The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle.
    Hum Reprod. 2022 May 11. pii: 6584540. doi: 10.1093.
    PubMed     Abstract available

    March 2022
  6. HAMEL CC, Vart P, Vandenbussche FPHA, Braat DDM, et al
    Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.
    Hum Reprod. 2022 Mar 25. pii: 6554030. doi: 10.1093.
    PubMed     Abstract available

    February 2022
  7. MIDDELKOOP MA, de Lange ME, Clark TJ, Mol BWJ, et al
    Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
    Hum Reprod. 2022 Feb 10. pii: 6526433. doi: 10.1093.
    PubMed     Abstract available

    May 2021
  8. SKORSTENGAARD M, Lynge E, Napolitano G, Blaakaer J, et al
    Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark.
    Hum Reprod. 2021 May 11. pii: 6273654. doi: 10.1093.
    PubMed     Abstract available

    April 2021
  9. LANGTON CR, Whitcomb BW, Purdue-Smithe AC, Sievert LL, et al
    Association of oral contraceptives and tubal ligation with risk of early natural menopause.
    Hum Reprod. 2021 Apr 2. pii: 6209119. doi: 10.1093.
    PubMed     Abstract available

    February 2021
  10. HALANE HIM, Hargreave M, Kjaer SK, Christensen J, et al
    Maternal use of hormonal contraception and epilepsy in offspring.
    Hum Reprod. 2021 Feb 13. pii: 6134728. doi: 10.1093.
    PubMed     Abstract available

    January 2021
  11. MONTOYA-BOTERO P, Martinez F, Rodriguez-Purata J, Rodriguez I, et al
    Erratum. The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF/ICSI cycles.
    Hum Reprod. 2021 Jan 30. pii: 6124104. doi: 10.1093.

    April 2020
  12. WAGNER JK, Dathe K, Schaefer C, Hoeltzenbein M, et al
    Ulipristal acetate and pregnancy outcome-an observational study.
    Hum Reprod. 2020 Apr 22. pii: 5823170. doi: 10.1093.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.